Fluid Therapy

流体疗法
  • 文章类型: Journal Article
    目的:确定与生理盐水相比,平衡溶液是否可以降低非体外循环冠状动脉搭桥术后急性肾损伤的发生率。
    方法:随机对照试验。
    方法:单一三级护理中心。
    方法:2014年6月至2020年7月期间接受非体外循环冠状动脉搭桥手术的患者。
    方法:基于平衡溶液的氯化物限制性静脉输液策略。
    结果:主要结局是术后7天内的急性肾损伤,根据2012年肾脏疾病:改善全球结果临床实践指南的定义。急性肾损伤的发生率在平衡组为4.4%(8/180),在生理盐水组为7.3%(13/178)。差异无统计学意义(风险差异、-2.86%;95%置信区间[CI],-7.72%至2.01%;风险比,0.61,95%CI,0.26至1.43;p=0.35)。与平衡组相比,生理盐水组术中血清氯化物水平较高,碱过量较低,这导致较低的pH。
    结论:在接受非体外循环旁路手术的患者中,肾小球滤过率估计正常,术中平衡的基于溶液的氯化物限制性静脉输液给药策略与基于盐水的氯化物-游离性静脉输液给药策略相比,没有降低术后急性肾损伤的发生率.
    OBJECTIVE: To determine whether balanced solutions can reduce the incidence of acute kidney injury after off-pump coronary artery bypass surgery compared with saline.
    METHODS: Randomized controlled trial.
    METHODS: Single tertiary care center.
    METHODS: Patients who underwent off-pump coronary artery bypass surgery between June 2014 and July 2020.
    METHODS: Balanced solution-based chloride-restrictive intravenous fluid strategy.
    RESULTS: The primary outcome was acute kidney injury within 7 postoperative days, as defined by the 2012 Kidney Disease: Improving Global Outcomes Clinical Practice Guideline. The incidence of acute kidney injury was 4.4% (8/180) in the balanced group and 7.3% (13/178) in the saline group. The difference was not statistically significant (risk difference, -2.86%; 95% confidence interval [CI], -7.72% to 2.01%; risk ratio, 0.61, 95% CI, 0.26 to 1.43; p = 0.35). Compared with the balanced group, the saline group had higher levels of intraoperative serum chloride and lower base excess, which resulted in a lower pH.
    CONCLUSIONS: In patients undergoing off-pump bypass surgery with a normal estimated glomerular filtration rate, the intraoperative balanced solution-based chloride-restrictive intravenous fluid administration strategy did not decrease the rate of postoperative acute kidney injury compared with the saline-based chloride-liberal intravenous fluid administration strategy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:严重创伤患者入住ICU后晶体复苏的时间趋势尚不清楚。我们假设早期晶体复苏与延迟晶体复苏相比,体积更小,结局更好。
    方法:回顾性,观察。
    方法:高容量1级学术创伤中心。
    方法:急诊ICU收治的成年创伤患者血清乳酸大于或等于4mmol/dL,ICU入院时乳酸升高(≥2mmol/L),和正常的乳酸48小时。
    方法:无。
    结果:对于333名受试者,我们分析了患者和损伤特征以及ICU前48小时的病程.ICU入院前6小时接受大于或等于500毫升/小时的晶体用于区分早期和早期晚期复苏.结果包括ICU住院时间(LOS),呼吸机日,急性肾损伤(AKI)。未调整和多变量回归方法用于比较早期复苏与晚期复苏.与早期复苏组相比,晚期复苏组48小时接受更多的容量(5.5vs.4.1L;p≤0.001),有更长的ICULOS(9vs.5d;p≤0.001),更多呼吸机天数(5vs.2d;p≤0.001),AKI发生率较高(38%vs.11%;p≤0.001)。在多元回归中,晚期复苏仍与较长的ICULOS和呼吸机天数以及较高的AKI几率相关.
    结论:与早期复苏相比,延迟复苏与48小时内更高的晶体量和更差的结局相关。在ICU入院早期给予明智的晶体液可改善严重受伤患者的预后。
    OBJECTIVE: The temporal trends of crystalloid resuscitation in severely injured trauma patients after ICU admission are not well characterized. We hypothesized early crystalloid resuscitation was associated with less volume and better outcomes than delaying crystalloid.
    METHODS: Retrospective, observational.
    METHODS: High-volume level 1 academic trauma center.
    METHODS: Adult trauma patients admitted to the ICU with emergency department serum lactate greater than or equal to 4 mmol/dL, elevated lactate (≥ 2 mmol/L) at ICU admission, and normal lactate by 48 hours.
    METHODS: None.
    RESULTS: For the 333 subjects, we analyzed patient and injury characteristics and the first 48 hours of ICU course. Receipt of greater than or equal to 500 mL/hr of crystalloid in the first 6 hours of ICU admission was used to distinguish early vs. late resuscitation. Outcomes included ICU length of stay (LOS), ventilator days, and acute kidney injury (AKI). Unadjusted and multivariable regression methods were used to compare early resuscitation vs. late resuscitation. Compared with the early resuscitation group, the late resuscitation group received more volume by 48 hours (5.5 vs. 4.1 L; p ≤ 0.001), had longer ICU LOS (9 vs. 5 d; p ≤ 0.001), more ventilator days (5 vs. 2 d; p ≤ 0.001), and higher occurrence rate of AKI (38% vs. 11%; p ≤ 0.001). On multivariable regression, late resuscitation remained associated with longer ICU LOS and ventilator days and higher odds of AKI.
    CONCLUSIONS: Delaying resuscitation is associated with both higher volumes of crystalloid by 48 hours and worse outcomes compared with early resuscitation. Judicious crystalloid given early in ICU admission could improve outcomes in the severely injured.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:胰腺手术与急性肾损伤(AKI)和临床相关的术后胰瘘(CR-POPF)的显著风险相关。这项研究评估了术中容量给药的影响,血管加压药治疗,和对胰腺手术后AKI的主要结局和CR-POPF的次要结局的血压管理。
    方法:这项回顾性单中心队列研究了200例连续胰腺手术(2018年1月至2021年12月)。根据AKI(肾脏疾病改善全球结果)和CR-POPF的存在/不存在对患者进行分类。单因素分析后,我们构建了多变量模型来控制主要和次要结局的单变量辅助因子差异.
    结果:在人口统计学(体重指数和性别)上有显著单变量差异的20例患者(10%)中发现了AKI,合并症,慢性肾功能不全的指标,和AKI风险评分增加。手术特点,术中液体,血管加压药,有和无AKI患者的血压管理相似.AKI患者失血增加,降低尿量,和包装红细胞管理。经过多变量分析,男性(OR=7.9,95%C.I.1.8-35.1)和AKI风险评分(OR=6.3,95%C.I.2.4-16.4)与AKI的发展相关(p<0.001)。术中和术后容量,血管加压药给药,在多变量分析中,术中低血压没有显著影响.在多变量分析中,有23例(11.9%)患者发生CR-POPF,无明显影响因素。发生AKI或CR-POPF的患者手术并发症增加,逗留时间,出院到熟练的护理机构,和死亡率。
    结论:在此分析中,术中容量给药,血管加压药治疗,血压<55mmHg超过10分钟与AKI风险增加无关。经过多变量分析,男性和AKI风险评分升高与AKI发生可能性增加相关.
    BACKGROUND: Pancreatic surgery is associated with a significant risk for acute kidney injury (AKI) and clinically relevant postoperative pancreatic fistula (CR-POPF). This investigation evaluated the impact of intraoperative volume administration, vasopressor therapy, and blood pressure management on the primary outcome of AKI and the secondary outcome of a CR-POPF after pancreatic surgery.
    METHODS: This retrospective single-center cohort investigated 200 consecutive pancreatic surgeries (January 2018-December 2021). Patients were categorized for the presence/absence of AKI (Kidney Disease Improving Global Outcomes) and CR-POPF. After univariate analysis, multivariable models were constructed to control for the univariate cofactor differences in the primary and secondary outcomes.
    RESULTS: AKI was identified in 20 patients (10%) with significant univariate differences in demographics (body mass index and gender), comorbidities, indices of chronic renal insufficiency, and an increased AKI Risk score. Surgical characteristics, intraoperative fluid, vasopressor, and blood pressure management were similar in patients with and without AKI. Patients with AKI had increased blood loss, lower urine output, and packed red blood cell administration. After multivariate analysis, male gender (OR = 7.9, 95% C.I. 1.8-35.1) and the AKI Risk score (OR = 6.3, 95% C.I. 2.4-16.4) were associated with the development of AKI (p < 0.001). Intraoperative and postoperative volume, vasopressor administration, and intraoperative hypotension had no significant impact in the multivariate analysis. CR-POPF occurred in 23 patients (11.9%) with no significant contributing factors in the multivariate analysis. Patients who developed AKI or a CR-POPF had an increase in surgical complications, length of stay, discharge to a skilled nursing facility, and mortality.
    CONCLUSIONS: In this analysis, intraoperative volume administration, vasopressor therapy, and a blood pressure < 55 mmHg for more than 10 min were not associated with an increased risk of AKI. After multivariate analysis, male gender and an elevated AKI Risk score were associated with an increased likelihood of AKI.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    为了治疗低血容量性休克,输液或输血对于解决容量不足至关重要。围绕低血容量性休克的复苏存在许多争议。我们旨在确定治疗低血容量性休克诱导猪模型的理想液体组合,分析生物电阻抗和血液动力学。将15只雌性三向杂交猪分为三个不同的组。三种复苏液为(1)平衡晶体,(2)平衡晶体+5%葡萄糖水,和(3)平衡晶体+20%白蛋白。实验分为三个阶段,依次进行:(1)控制性出血(1L出血,60分钟),(2)复苏期1(1L液体输注,60分钟),和(3)复苏阶段2(1L液体输注,60分钟)。使用分段多频生物电阻抗分析仪进行生物电阻抗分析。在猪的五个区段中的六个不同频率下,对每只猪评估总共61次阻抗测量。脉搏率(PR),平均动脉压(MAP),每搏输出量(SV),和每搏输出量变化(SVV)使用微创血流动力学监测装置进行测量.当输注1升平衡晶体+1升5%葡萄糖水和1.6升平衡晶体+400毫升20%白蛋白时,该三维图显示出弯曲的图案。在控制出血期间,所有组的1M阻抗均增加,从输液到实验结束持续下降。在流体输注结束后,仅平衡的类晶体+20%白蛋白将MAP和SV显著恢复到与实验开始相同的水平。各组MAP和SV从恢复到1M阻抗初值至输液结束无显著差异。MAP和SV等血液动力学指标的变化和恢复与1M阻抗的变化和恢复一致。在低血容量性休克诱导的猪模型中使用与20%白蛋白混合的平衡晶体可能有助于确保血液动力学稳定性。与平衡晶体单次给药相比。
    To treat hypovolemic shock, fluid infusion or blood transfusion is essential to address insufficient volume. Much controversy surrounds resuscitation in hypovolemic shock. We aimed to identify the ideal fluid combination for treating hypovolemic shock-induced swine model, analyzing bioelectrical impedance and hemodynamics. Fifteen female three-way crossbred pigs were divided into three different groups. The three resuscitation fluids were (1) balanced crystalloid, (2) balanced crystalloid + 5% dextrose water, and (3) balanced crystalloid + 20% albumin. The experiment was divided into three phases and conducted sequentially: (1) controlled hemorrhage (1 L bleeding, 60 min), (2) resuscitation phase 1 (1 L fluid infusion, 60 min), and (3) resuscitation phase 2 (1 L fluid infusion, 60 min). Bioelectrical impedance analysis was implemented with a segmental multifrequency bioelectrical impedance analyzer. A total of 61 impedance measurements were assessed for each pig at six different frequencies in five segments of the pig. Pulse rate (PR), mean arterial pressure (MAP), stroke volume (SV), and stroke volume variation (SVV) were measured using a minimally invasive hemodynamic monitoring device. The three-dimensional graph showed a curved pattern when infused with 1 L of balanced crystalloid + 1 L of 5% dextrose water and 1.6 L of balanced crystalloid + 400 ml of 20% albumin. The 1M impedance increased in all groups during the controlled hemorrhage, and continuously decreased from fluid infusion to the end of the experiment. Only balanced crystalloid + 20% albumin significantly restored MAP and SV to the same level as the start of the experiment after the end of fluid infusion. There were no significant differences in MAP and SV from the time of recovery to the initial value of 1M impedance to the end of fluid infusion in all groups. The change and the recovery of hemodynamic indices such as MAP and SV coincide with the change and the recovery of 1M impedance. Using balanced crystalloid mixed with 20% albumin in hypovolemic shock-induced swine model may be helpful in securing hemodynamic stability, compared with balanced crystalloid single administration.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:内镜逆行胰胆管造影术(ERCP)在胰胆管疾病的治疗中起着不可或缺的作用,但存在ERCP后胰腺炎(PEP)的风险。尽管预防战略取得了进展,PEP的预防仍然不完善,需要更精细的水合方法。这项研究调查了乳酸林格液与血浆溶液预防PEP的有效性。
    方法:这个多中心,双盲,随机对照试验,将由研究者发起,并在韩国的三个高等教育中心进行。这项研究的目的是评估水合在预防初治乳头患者PEP中的有效性。它将针对幼稚乳头的患者,重点关注PEP中高风险人群。年龄≤18岁的患者和有严重合并症的患者,急性/慢性胰腺炎和其他各种医疗条件将被排除。符合条件的参与者将被随机分为两组,数量相等:(1)使用乳酸林格氏溶液预防PEP和(2)使用血浆溶液预防PEP。这项研究的主要结果将是PEP的发生,次要结局将是与ERCP相关的其他危险因素和潜在不良事件.共有844名患者,这项研究将能够发现干预组之间的显著差异。
    背景:从每个机构获得道德批准(阿山医疗中心,2023-0382;首尔国立大学医院,H-2302-05-1404;三星医疗中心,SMC2023-02-001-009)。所有参与者在明确解释研究程序后提供知情同意书。研究结果将在同行评审的期刊和研究会议上传播。
    背景:NCT05832047。
    方法:第4.1版(2023年)。
    BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) plays an indispensable role in treating pancreato-biliary diseases but carries a risk of post-ERCP pancreatitis (PEP). Despite advances in the prevention strategies, prevention of PEP remains imperfect, necessitating more refined hydration methods. This study investigates the effectiveness of lactated Ringer\'s solution versus plasma solution in preventing PEP.
    METHODS: This multicentre, double-blind, randomised controlled trial, will be initiated by the investigator-sponsor, and conducted in three tertiary centres in South Korea. The aim of this study is to assess the effectiveness of hydration in preventing PEP in patients with naïve papillae. It will target patients with naïve papillae, focusing on those at medium to high risk of PEP. Patients aged ≤18 years and those with serious comorbidities, acute/chronic pancreatitis and various other medical conditions will be excluded. Eligible participants will be randomly assigned into two arms in equal numbers: (1) PEP prevention using lactated Ringer\'s solution and (2) PEP prevention using plasma solution. The primary outcome of this study will be the occurrence of PEP, and secondary outcomes will be additional risk factors and potential adverse events related to ERCP. With a total enrolment of 844 patients, the study will be able to detect significant differences between the intervention arms.
    BACKGROUND: Ethical approval is obtained from each institution (Asan Medical Centre, 2023-0382; Seoul National University Hospital, H-2302-05-1404; Samsung Medical Centre, SMC 2023-02-001-009). All participants provided informed consent following clear explanation of the study procedures. The results of the study will be disseminated in peer-reviewed journals and research conferences.
    BACKGROUND: NCT05832047.
    METHODS: Ver 4.1 (2023).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    成人患者的临床辅助营养和水合(CANH)决策提出了复杂的道德困境,需要仔细考虑和导航。这篇临床综述讨论了CANH的多方面问题,强调伦理框架的重要性和高级临床从业人员(ACP)在指导决策过程中的作用。强调了ACP的关键作用,从他们在决策中的责任和挑战到他们促进患者参与的协作方法,家庭和多学科团队。文章还探讨了自治等道德原则,仁慈,非恶意,和正义,阐明其在CANH决策中的应用。审查了涵盖CANH的法律和道德框架,以及说明道德困境和解决方案的案例研究。讨论了以患者为中心的CANH决策方法,强调有效的沟通和考虑文化和宗教信仰。还检查了CANH的临终考虑和姑息治疗,包括过渡到姑息治疗和退出或扣留CANH的伦理考虑。概述了未来的研究方向和对临床实践的影响,强调需要持续的道德反思和ACP在CANH决策中的整合。
    Clinically assisted nutrition and hydration (CANH) decision-making in adult patients presents complex ethical dilemmas that require careful consideration and navigation. This clinical review addresses the multifaceted aspects of CANH, emphasising the importance of ethical frameworks and the role of advanced clinical practitioners (ACPs) in guiding decision-making processes. The pivotal role of ACPs is highlighted, from their responsibilities and challenges in decision-making to the collaborative approach they facilitate involving patients, families and multidisciplinary teams. The article also explores ethical principles such as autonomy, beneficence, non-maleficence, and justice, elucidating their application in CANH decision-making. Legal and ethical frameworks covering CANH are examined, alongside case studies illustrating ethical dilemmas and resolutions. Patient-centred approaches to CANH decision-making are discussed, emphasising effective communication and consideration of cultural and religious beliefs. End-of-life considerations and palliative care in CANH are also examined, including the transition to palliative care and ethical considerations in withdrawal or withholding of CANH. Future directions for research and implications for clinical practice are outlined, highlighting the need for ongoing ethical reflection and the integration of ACPs in CANH decision-making.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目标:心脏手术后,与含晶体的FBT相比,含20%人白蛋白的液体推注疗法(FBT)可促进较少的液体和血管加压药给药.我们的目标是确定是否,心脏手术后,与晶体FBT相比,含20%白蛋白的FBT可减少血管加压药治疗的持续时间。
    方法:我们进行了多中心,平行组,开放标签,在六个重症监护病房(ICU)进行的随机临床试验,涉及被认为需要FBT的心脏手术患者。我们随机分配240例患者接受高达400毫升的20%白蛋白/天作为FBT,之后是4%的白蛋白,用于当天的任何后续FBT,或至少第一个1000毫升的晶体FBT,此后使用晶体或4%白蛋白FBT。主要结果是血管加压药治疗的累积持续时间。次要结果包括液体平衡。
    结果:在480名随机患者中,466提供同意并促成主要结局(平均年龄65岁;中位数EuroSCOREII1.4)。血管加压药治疗的累积中位持续时间为7(四分位距[IQR]0-19.6)小时,白蛋白为20%,晶体液为10.8(IQR0-22.8)小时(差异-3.8小时,95%置信区间[CI]-8至0.4;P=0.08)。使用20%白蛋白FBT的第一天液体平衡较少(平均差-701mL,95%CI-872至-530)。
    结论:心脏手术后的患者,与基于晶体的FBT相比,20%白蛋白FBT与体液正平衡降低相关,但并未显著缩短血管升压药治疗的持续时间。
    OBJECTIVE: After cardiac surgery, fluid bolus therapy (FBT) with 20% human albumin may facilitate less fluid and vasopressor administration than FBT with crystalloids. We aimed to determine whether, after cardiac surgery, FBT with 20% albumin reduces the duration of vasopressor therapy compared with crystalloid FBT.
    METHODS: We conducted a multicentre, parallel-group, open-label, randomised clinical trial in six intensive care units (ICUs) involving cardiac surgery patients deemed to require FBT. We randomised 240 patients to receive up to 400 mL of 20% albumin/day as FBT, followed by 4% albumin for any subsequent FBT on that day, or to crystalloid FBT for at least the first 1000 mL, with use of crystalloid or 4% albumin FBT thereafter. The primary outcome was the cumulative duration of vasopressor therapy. Secondary outcomes included fluid balance.
    RESULTS: Of 480 randomised patients, 466 provided consent and contributed to the primary outcome (mean age 65 years; median EuroSCORE II 1.4). The cumulative median duration of vasopressor therapy was 7 (interquartile range [IQR] 0-19.6) hours with 20% albumin and 10.8 (IQR 0-22.8) hours with crystalloids (difference - 3.8 h, 95% confidence interval [CI] - 8 to 0.4; P = 0.08). Day one fluid balance was less with 20% albumin FBT (mean difference - 701 mL, 95% CI - 872 to - 530).
    CONCLUSIONS: In patients after cardiac surgery, when compared to a crystalloid-based FBT, 20% albumin FBT was associated with a reduced positive fluid balance but did not significantly reduce the duration of vasopressor therapy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Letter
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目标:微型流体挑战(MFC),它评估了100mL晶体给药后的每搏输出量指数(SVI)的变化,和短时低呼气末正压(PEEP)挑战(SLPC),它评估由于PEEP增加而导致的SVI暂时减少,是两种用于预测手术室液体反应性的功能性血液动力学测试。然而,SLPC尚未在接受腹部手术的患者中进行评估,并且在剖腹手术中没有比较这两种方法的研究。因此,我们旨在比较接受开放式胰十二指肠切除术患者的SLPC和MFC.
    方法:所有患者均接受标准的血流动力学管理。研究方案评估了在施加额外的5cmH2OPEEP(SVIΔ%-SLPC)和输注100mL晶体(SVIΔ%-MFC)之后SVI的百分比变化。在500ml流体加载后导致SVI增加超过15%的挑战被分类为积极挑战(PC)。使用接受者工作特征曲线下的面积(ROCAUC)来比较这些方法。
    结果:33名患者以94次挑战完成了研究。其中55(58.5%)是PC。SVIΔ%-MFC的ROCAUC显著高于SVIΔ%-SLPC(0.97vs.0.64,p<0.001)。SVIΔ%-MFC的最佳截断值为5.6%。如果当观察到SVIΔ%-MFC≤5%(灰色区域的下限)时,我们停止了推注液给药,在39项负面挑战中,我们会推迟35项(89.7%)的液体加载。延迟的流体量将相当于给定总流体的高达40%。
    结论:SVIΔ%-MFC预测开放胰十二指肠切除术患者的液体反应性具有较高的诊断性能,优于SVIΔ%-SLPC。此外,SVIΔ%-MFC的使用有可能延迟高达所给总流体的40%。
    结果:gov:NCT05419570。
    OBJECTIVE: The mini-fluid challenge (MFC), which assesses the change in stroke volume index (SVI) following the administration of 100 mL of crystalloids, and the short-time low positive end-expiratory pressure (PEEP) challenge (SLPC), which evaluates the temporary reduction in SVI due to a PEEP increment, are two functional hemodynamic tests used to predict fluid responsiveness in the operating room. However, SLPC has not been assessed in patients undergoing abdominal surgery, and there is no study comparing these two methods during laparotomy. Therefore, we aimed to compare the SLPC and MFC in patients undergoing open pancreaticoduodenectomy.
    METHODS: All patients received a standard hemodynamic management. The study protocol evaluated the percentage change in SVI following the application of an additional 5 cmH2O PEEP (SVIΔ%-SLPC) and the infusion of 100 mL crystalloid (SVIΔ%-MFC). Challenges that resulted in an increase of more than 15% in SVI after the 500 ml of fluid loading were classified as positive challenges (PC). Areas under the receiver operating characteristics curves (ROC AUCs) were used for the comparison of the methods.
    RESULTS: Thirty-three patients completed the study with 94 challenges. Fifty-five (58.5%) of them were PCs. The ROC AUC of SVIΔ%-MFC was observed to be significantly higher than that of SVIΔ%-SLPC (0.97 vs. 0.64, p < 0.001). The best cut-off value for SVIΔ%-MFC was 5.6%. If we had stopped the bolus fluid administration when SVIΔ%-MFC ≤ 5% was observed (lower limit of the gray zone), we would have postponed the fluid loading in 35 (89.7%) of 39 negative challenges. The amount of fluid deferred would have corresponded to up to 40% of the total fluid given.
    CONCLUSIONS: SVIΔ%-MFC predicts fluid responsiveness with high diagnostic performance and is better than SVIΔ%-SLPC in patients undergoing open pancreatoduodenectomy. Additionally, the use of SVIΔ%-MFC has the potential to defer up to 40% of the total fluid given.
    RESULTS: gov: NCT05419570.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:美国国家健康与护理卓越研究所(NICE)的成人医院维持液体治疗指南被广泛使用,但是这些建议没有得到适当的评估。在这项研究中,我们调查了提供25-30mL/kg/天的液体和1mmol/kg钠和钾的建议是否足以满足人类需求.
    方法:首先,我们计算了在交叉输注实验期间细胞外液体积(ECV)和细胞内液体积(ICV)之间的液体分布,其中12名志愿者在48小时内接受25毫升/千克的高钠(154毫摩尔/升)或低钠(54毫摩尔/升)溶液。719名志愿者和临床患者的尿液样本被用来量化他们的肾脏水保护和钠和钾的排泄。第三,对一项饮食研究的回顾性分析用于推断719名志愿者和接受尿液输送的医院患者的液体摄入量和电解质排泄可能有多大.
    结果:高钠液维持ECV,但ICV在48小时后降低了1.3L。低钠液导致1.7L的体积不足,对ECV和ICV的影响相等。基于饮食研究的回归方程表明,719名受试者的每日平均饮水量为2.6L,排泄了2mmol/kg的钠和1mmol/kg的钾。
    结论:NICE指南建议人类水和钠过少,无法充分维持ECV和ICV。
    背景:EudraCT2016-001846-24和ISRCTN12215472。
    OBJECTIVE: The National Institute for Health and Care Excellence\'s (NICE) Guideline for Maintenance Fluid Therapy in Adults in Hospital is widely used, but the recommendations have not been evaluated properly. In this study, we investigated whether the recommendation of providing 25-30 mL/kg/day of fluid and 1 mmol/kg each of sodium and potassium is sufficient for human needs.
    METHODS: First, we calculated the distribution of fluid between the extracellular fluid volume (ECV) and intracellular fluid volume (ICV) during a cross-over infusion experiment where 12 volunteers received 25 mL/kg/day of either a high-sodium (154 mmol/L) or low-sodium (54 mmol/L) solution over 48 h. Second, urine samples from 719 volunteers and clinical patients were used to quantify their renal water conservation and excretion of sodium and potassium. Third, retrospective analysis of a diet study was used to extrapolate how large the fluid intake and the electrolyte excretion likely had been in the 719 volunteers and hospital patients who delivered urine.
    RESULTS: The high-sodium fluid maintained the ECV but the ICV had decreased by 1.3 L after 48 h. The low-sodium fluid resulted in a volume deficit of 1.7 L that equally affected the ECV and the ICV. Regression equations based on the diet study suggested that the daily intake of water in the 719 subjects averaged 2.6 L and that 2 mmol/kg of sodium and 1 mmol/kg of potassium was excreted.
    CONCLUSIONS: The NICE guideline recommends too little water and sodium for a human to adequately maintain the ECV and ICV.
    BACKGROUND: EudraCT 2016-001846-24 and ISRCTN 12215472.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号